Found 81 matching trials
Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer NA The goal of this clinical trial is to evaluate the efficacy and safety of t...
Show More Location
The Central Hospital of Wuhan
Learn More & Join Trial
Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC PHASE2 To explore the efficiency and safety of Tislelizumab combinated with carbop...
Show More Location
Multiple Locations
Learn More & Join Trial
Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC PHASE2 This is a Phase II single-arm study designed to evaluate the efficacy and s...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors PHASE1 The primary objective of this study is to assess the safety and tolerabilit...
Show More Location
Icahn School of Medicine At Mount Sinai
Learn More & Join Trial
A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer PHASE3 The purpose of this study was to evaluate the safety and efficacy of ociper...
Show More Location
XCancer/Centeral Care Center
Learn More & Join Trial
Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC PHASE2 To explore the related biomarkers for safety and efficacy of the combinatio...
Show More Location
Guangzhou Medical University Affiliated Cancer Hospital
Learn More & Join Trial
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer PHASE2 This study aimed to evaluate the safety and effectiveness of ociperlimab co...
Show More Location
Valkyrie Clinical Trials
Learn More & Join Trial
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma PHASE2 This study aims to investigate the efficacy and safety of low-dose radiatio...
Show More Location
Sichuan University West China Hospital
Learn More & Join Trial
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC PHASE2 The aim of this clinical trial is to understand whether spatial fractionate...
Show More Location
Nanchang City, Jiangxi Province
Learn More & Join Trial
Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC PHASE2 This prospective, single-arm, Phase II study aims to evaluate the efficacy,...
Show More Location
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Learn More & Join Trial